Northpond Ventures LP 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-23 5:10 pm Sale | 2023-06-22 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 800,000 1.700% | -2,492,871 (-75.71%) | Filing |
| 2022-11-10 4:15 pm Unchanged | 2022-11-09 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 6.900% | 0 (Unchanged) | Filing |
| 2021-09-28 06:04 am Purchase | 2021-09-17 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 9.100% | 3,292,871 (New Position) | Filing |